Effect of Risedronate and Alendronate Treatment on Femoral Bone Quality and Collagen Integrity

被引:0
|
作者
Bagis, Selda [1 ]
Comelekoglu, Ulku [1 ]
Yalin, Serap [1 ]
Yilmaz, Nejat [1 ]
Ogenler, Oya [1 ]
Yildiz, Altan [1 ]
Nayci, Ali [1 ]
机构
[1] Mersin Univ, Sch Med, Dept Biophys, TR-33169 Mersin, Turkey
关键词
Alendronate; Risedronate; Bone strength; Collagen; Bone biomechanic; MECHANICAL-PROPERTIES; OVARIECTOMIZED RATS; TRABECULAR BONE; POSTMENOPAUSAL OSTEOPOROSIS; RANDOMIZED-TRIAL; STRENGTH; WOMEN; MASS; MATRIX; BISPHOSPHONATES;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The aim of this study was to investigate the effect of risedronate and alendronate treatment on bone biomechanical parameters and bone collagen integrity during postmenopausal osteoporosis. Sixty Sprague-Dawley female rats were divided into four groups: I, control (CON, n = 15); II, ovariectomized (OVX, n = 15); III, ovariectomized + alendronate (OVX-ALN, n = 15) and IV, ovariectomized + risedronate (OVX-RIS. n = 15). Ten weeks after ovariectomy, OVX-ALN rats were treated with alendronate sodium at the dose of 1.75 mg/kg body weight and OVX-RIS rats received risedronate sodium at the dose of 0.5 mg/kg body weight using gavage twice per week for 12 weeks. Biomechanical measurements were performed at the femoral shaft and femoral neck of the left femur. In the OVX-ALN and OVX-RIS groups, strength, displacement. energy, strain and toughness were significantly increased when compared to OVX group. There were no significant differences between control and OVX-ALN and OVX-RIS groups for all biomechanical parameters at the femoral diaphysis and femoral neck. There were no statistically significant differences between the control, OVX, OVX-ALN and OVX-RIS groups with respect to biochemical parameters. Normal collagen fiber organization was observed in control group, whereas the parallel packing of fibrils were completely replaced by a random arrangement in ovariectomized rats. However. OVX-ALN and OVX-RIS groups showed more regular arrangement than OVX group. In conclusion. the positive effect on bone biomechanical parameters and collagen integrity in ovariectomized rat femur was observed following the treatment of risedronate and alendronate.
引用
收藏
页码:1033 / 1041
页数:9
相关论文
共 50 条
  • [31] Switching from branded alendronate or risedronate to generic alendronate: Effect on persistence with bisphosphonate therapy in Germany
    Ziller, V.
    Schuessel, K.
    Czeche, S.
    Franzmann, A.
    Kloeckner, D.
    Quinzler, R.
    Schulz, M.
    Moehrke, W.
    Hadji, P.
    BONE, 2009, 44 (02) : S449 - S450
  • [32] Alendronate and risedronate but not etidronate inhibit bone resorption without inducing apoptosis.
    Halasy-Nagy, JM
    Rodan, GA
    Reszka, AA
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S406 - S406
  • [33] Alendronate treatment results in similar levels of trabecular bone remodeling in the femoral neck and vertebra
    T. Diab
    M. R. Allen
    D. B. Burr
    Osteoporosis International, 2009, 20 : 647 - 652
  • [34] SWITCHING FROM BRANDED ALENDRONATE OR RISEDRONATE TO GENERIC ALENDRONATE: EFFECT ON PERSISTENCE WITH BISPHOSPHONATE THERAPY IN GERMANY
    Ziller, V.
    Schuessel, K.
    Czeche, S.
    Franzmann, A.
    Kloeckner, D.
    Quinzler, R.
    Schulz, M.
    Moehrke, W.
    Hadji, P.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 112 - 112
  • [35] Alendronate treatment results in similar levels of trabecular bone remodeling in the femoral neck and vertebra
    Diab, T.
    Allen, M. R.
    Burr, D. B.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (04) : 647 - 652
  • [36] The effects of alendronate on bone turnover and bone quality
    Meunier, PJ
    Arlot, M
    Chavassieux, P
    Yates, AJ
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, : 14 - 17
  • [37] Novel combinatorial transdermal drug delivery of alendronate with risedronate for the treatment of osteoporosis
    Kong, Fanguo
    Jia, Bin
    Cui, Peng
    Wang, Duojun
    ACTA BIOCHIMICA POLONICA, 2019, 66 (04) : 463 - 467
  • [38] Pharmacoeconomic analysis of the treatment of post-menopausal osteoporosis with risedronate or alendronate
    Hart, WM
    Rubio-Terrés, C
    Burrell, A
    Aristegui, I
    Escobar, F
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S47 - S47
  • [39] Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women
    Ringe, J. D.
    Christodoulakos, G. E.
    Mellstroem, D.
    Petto, H.
    Nickelsen, T.
    Marin, F.
    Pavo, I.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (11) : 2677 - 2687
  • [40] Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate
    Yano, Tetsuo
    Yamada, Mei
    Inoue, Daisuke
    CALCIFIED TISSUE INTERNATIONAL, 2017, 101 (01) : 102 - 110